Novartis Consumer Health North America Head Piergallini To Lead Worldwide
This article was originally published in The Tan Sheet
Novartis Consumer Health North America head Al Piergallini will take over as head of Consumer Health worldwide, succeeding Thomas Ebeling, who has been named worldwide chief operating officer of pharmaceuticals under division CEO Jerry Karabelas. Piergallini will continue to lead North America as well; a replacement will not be sought immediately, the company said.
You may also be interested in...
Novartis plans to spend $20 mil. on TV and print advertising in 1999 to launch Lamisil AT, the firm's new OTC athlete's foot medication. An Rx-to-OTC switch of the 1% terbinafine cream was approved by FDA March 9 ("The Tan Sheet" March 15, p. 11).
Novartis said its new OTC athlete's foot medication Lamisil AT Cream is the only nonprescription medication that cures athlete's foot with one week of treatment in its announcement that FDA has approved the Rx-to-OTC switch.
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC